Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc (NasdaqGS:MGTX) for approximately $130 million on December 21, 2023. As part of consideration $65 million will pay at signing, an additional $50 million anticipated in the first quarter of 2024, with the remaining $15 million in milestone payments expected later in 2024. Evercore Group L.L.C. acted as financial advisor to MeiraGTx Holdings plc (NasdaqGS:MGTX) and Morgan, Lewis & Bockius LLP acted as legal advisor to MeiraGTx Holdings plc (NasdaqGS:MGTX).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.07 USD | -0.59% | +1.40% | -27.78% |
09/05 | Earnings Flash (MGTX) MEIRAGTX Reports Q1 Revenue $697,000 | MT |
09/05 | MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.78% | 326M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MGTX Stock
- News MeiraGTx Holdings plc
- Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc for approximately $130 million.